Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06342492 · ClinicalTrials.gov registry record
Conduction System Vs Surgical Left Ventricular Epicardial Pacing For Coronary Sinus Lead Failure
A clinical trial of Heart Failure With Reduced Ejection Fraction, sponsored by Kansas City Heart Rhythm Research Foundation.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06342492: Recruiting study of Heart Failure With Reduced Ejection Fraction, sponsored by Kansas City Heart Rhythm Research Foundation.
NCT06342492 is a study of Heart Failure With Reduced Ejection Fraction that is actively recruiting participants, run by Kansas City Heart Rhythm Research Foundation. The registered enrollment target is 100 participants, below the 3,962-participant average among 27 other Heart Failure With Reduced Ejection Fraction trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06342492, a study of Heart Failure With Reduced Ejection Fraction, is actively recruiting participants, sponsored by Kansas City Heart Rhythm Research Foundation.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This a single-center, retrospective, observational study of patients that undergo coronary sinus(CS) lead revision, comparing epicardial lead placement to coronary sinus pacing(CSP) in those that had lead failure.
Primary Outcome
Compare the need for lead revision between conduction system pacing (CSP) and transthoracic left ventricular (LV) epicardial pacing approach
Conditions Studied
Interventions
- OTHER Coronary Sinus Lead Revision
Study Locations (1)
Kansas
- Kansas City Heart Rhythm Institute - Overland Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-11-07 |
| Est. Completion | 2024-12 |
What NCT06342492 shows while recruiting
NCT06342492 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 3,962-participant average among 27 other Heart Failure With Reduced Ejection Fraction trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Heart Failure With Reduced Ejection Fraction appearing as the primary indexed condition, and to 1 intervention - of which Coronary Sinus Lead Revision is the first listed.
NCT06342492 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT06342492 about?
NCT06342492 is a clinical study titled "Conduction System Vs Surgical Left Ventricular Epicardial Pacing For Coronary Sinus Lead Failure". This a single-center, retrospective, observational study of patients that undergo coronary sinus(CS) lead revision, comparing epicardial lead placement to coronary sinus pacing(CSP) in those that had lead failure.
What is the current status of trial NCT06342492?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-11-07. Estimated completion is 2024-12.
What conditions does trial NCT06342492 study?
This clinical trial studies the following conditions: Heart Failure With Reduced Ejection Fraction.
What interventions are being tested in trial NCT06342492?
The interventions under investigation include: Coronary Sinus Lead Revision (OTHER).
Who is sponsoring clinical trial NCT06342492?
This trial is sponsored by Kansas City Heart Rhythm Research Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06342492 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure With Reduced Ejection Fraction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06342492's enrollment target sits among peer trials
100 15th of 27 higher than 12 of 27 other Heart Failure With Reduced Ejection Fraction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure With Reduced Ejection Fraction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
-
Pilot Study Lp299v Supplementation in Chronic Heart Failure
RECRUITING · NA
-
PRIME HFrEF: Novel Exercise for Older Patients With Heart Failure With Reduced Ejection Fraction
RECRUITING · NA
-
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
RECRUITING
-
Study of JK07 in Patients With Chronic Heart Failure
RECRUITING · Phase 2
-
Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI